CY2020034I1 - Κεφαλοσπορινη που διαθετει ομαδα κατεχολης - Google Patents

Κεφαλοσπορινη που διαθετει ομαδα κατεχολης

Info

Publication number
CY2020034I1
CY2020034I1 CY2020034C CY2020034C CY2020034I1 CY 2020034 I1 CY2020034 I1 CY 2020034I1 CY 2020034 C CY2020034 C CY 2020034C CY 2020034 C CY2020034 C CY 2020034C CY 2020034 I1 CY2020034 I1 CY 2020034I1
Authority
CY
Cyprus
Prior art keywords
cephalosporin
catechol group
catechol
group
Prior art date
Application number
CY2020034C
Other languages
English (en)
Other versions
CY2020034I2 (el
Original Assignee
Shionogi & Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42128829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2020034(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co., Ltd. filed Critical Shionogi & Co., Ltd.
Publication of CY2020034I1 publication Critical patent/CY2020034I1/el
Publication of CY2020034I2 publication Critical patent/CY2020034I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D505/10—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D505/12—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7
    • C07D505/14—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7 with hetero atoms directly attached in position 7
    • C07D505/16—Nitrogen atoms
    • C07D505/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D505/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D505/24—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by doubly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/06—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 containing at least one condensed beta-lactam ring system, provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00, e.g. a penem or a cepham system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY2020034C 2008-10-31 2020-10-16 Κεφαλοσπορινη που διαθετει ομαδα κατεχολης CY2020034I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008280828 2008-10-31
EP09823578.1A EP2341053B1 (en) 2008-10-31 2009-10-27 Cephalosporin having catechol group

Publications (2)

Publication Number Publication Date
CY2020034I1 true CY2020034I1 (el) 2020-11-25
CY2020034I2 CY2020034I2 (el) 2021-05-05

Family

ID=42128829

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20161101180T CY1118536T1 (el) 2008-10-31 2016-11-16 Κεφαλοσπορινη που διαθετει ομαδα κατεχολης
CY2020034C CY2020034I2 (el) 2008-10-31 2020-10-16 Κεφαλοσπορινη που διαθετει ομαδα κατεχολης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20161101180T CY1118536T1 (el) 2008-10-31 2016-11-16 Κεφαλοσπορινη που διαθετει ομαδα κατεχολης

Country Status (38)

Country Link
US (1) US9238657B2 (el)
EP (2) EP2960244B1 (el)
JP (2) JP5498393B2 (el)
KR (1) KR101655961B1 (el)
CN (1) CN102203100B (el)
AU (1) AU2009310959B2 (el)
BR (1) BRPI0921701B8 (el)
CA (1) CA2736953C (el)
CL (1) CL2011000939A1 (el)
CO (1) CO6331443A2 (el)
CR (1) CR20110144A (el)
CY (2) CY1118536T1 (el)
DK (1) DK2960244T3 (el)
EA (1) EA019520B1 (el)
ES (2) ES2602969T3 (el)
FI (1) FIC20200039I1 (el)
FR (1) FR20C1050I2 (el)
HR (1) HRP20161408T1 (el)
HU (2) HUE031802T2 (el)
IL (1) IL211720A (el)
LT (2) LT2960244T (el)
MA (1) MA32731B1 (el)
ME (1) ME02666B (el)
MX (1) MX2011004636A (el)
MY (1) MY155655A (el)
NL (1) NL301067I2 (el)
NO (1) NO2020035I1 (el)
NZ (1) NZ591728A (el)
PE (1) PE20120010A1 (el)
PL (1) PL2960244T3 (el)
PT (1) PT2960244T (el)
RS (1) RS55365B1 (el)
SI (1) SI2960244T1 (el)
SM (1) SMT201600397B (el)
TW (1) TWI535727B (el)
UA (1) UA105190C2 (el)
WO (1) WO2010050468A1 (el)
ZA (1) ZA201102024B (el)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049086A1 (en) 2007-10-09 2009-04-16 Larry Sutton Broad spectrum beta-lactamase inhibitors
MY155655A (en) 2008-10-31 2015-11-13 Shionogi & Co Cephalosporin having catechol group
EP2557082A4 (en) * 2010-04-05 2013-08-28 Shionogi & Co CEPHEM COMPOUND COMPRISING A CATÉCHOL GROUP
WO2011125966A1 (ja) * 2010-04-05 2011-10-13 塩野義製薬株式会社 擬似カテコール基を有するセフェム化合物
US9085589B2 (en) 2010-04-28 2015-07-21 Shionogi & Co., Ltd. Cephem derivative
US20150072396A1 (en) 2011-03-04 2015-03-12 Life Technologies Corporation Compounds and Methods for Conjugation of Biomolecules
KR101719556B1 (ko) * 2011-03-30 2017-03-24 주식회사 레고켐 바이오사이언스 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물
WO2012147773A1 (ja) 2011-04-28 2012-11-01 塩野義製薬株式会社 カテコールまたは擬似カテコール構造を有する新規セフェム化合物
JPWO2013002215A1 (ja) 2011-06-27 2015-02-23 塩野義製薬株式会社 ピリジニウム基を有するセフェム化合物
TWI547496B (zh) 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物
CN103958527A (zh) 2011-10-04 2014-07-30 盐野义制药株式会社 具有儿茶酚基团的头孢烯衍生物
UY35103A (es) 2012-10-29 2014-05-30 Glaxo Group Ltd Compuestos de cefem 2-sustituidos
CA2888543A1 (en) 2012-10-29 2014-05-08 Shionogi & Co., Ltd. Processes for production of intermediates for 2-alkyl cephem compounds
JPWO2014104148A1 (ja) * 2012-12-26 2017-01-12 塩野義製薬株式会社 セフェム化合物
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
TWI714525B (zh) 2014-03-24 2021-01-01 瑞士商諾華公司 用於治療細菌感染之單內醯胺（ｍｏｎｏｂａｃｔａｍ）有機化合物
JP6377570B2 (ja) * 2014-04-28 2018-08-22 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ ２−置換セフェム化合物を含有する医薬組成物
KR102396753B1 (ko) 2014-06-11 2022-05-12 베나토알엑스 파마슈티컬스, 인크. 베타-락타마제 억제제
CN106687116B (zh) * 2014-09-04 2020-07-24 盐野义制药株式会社 含有具有儿茶酚基的头孢菌素类的制剂
JP6783497B2 (ja) * 2014-09-04 2020-11-11 塩野義製薬株式会社 セファロスポリン誘導体の中間体およびその製造方法
AU2015312828B2 (en) * 2014-09-04 2020-02-13 Shionogi & Co., Ltd. Salt of cephalosporin derivative, crystalline solid form of same and method for producing same
WO2016198691A1 (en) 2015-06-11 2016-12-15 Basilea Pharmaceutica Ag Efflux-pump inhibitors and therapeutic uses thereof
DK3353175T3 (da) 2015-09-23 2020-09-14 Novartis Ag Salte og faste former af et monobactam-antibiotikum
CA3005779C (en) * 2015-12-10 2020-04-07 Naeja-Rgm Pharmaceuticals Ulc Cephem compounds, their production and use
EP3426656B1 (en) 2016-03-08 2021-05-12 Novartis AG Tricyclic compounds useful to treat orthomyxovirus infections
EP3471724A1 (en) * 2016-06-17 2019-04-24 Wockhardt Limited Antibacterial compositions
JOP20170169A1 (ar) 2016-08-29 2019-01-30 Novartis Ag مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو
WO2018218154A1 (en) 2017-05-26 2018-11-29 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
US10933051B2 (en) * 2017-06-09 2021-03-02 Fob Synthesis, Inc. Carbapenem compounds and compositions for the treatment of bacterial infections
WO2019026004A2 (en) 2017-08-02 2019-02-07 Novartis Ag CHEMICAL PROCESS FOR THE PREPARATION OF ANTIBIOTIC MONOBACTAM AND ITS INTERMEDIATES
SG11202007718SA (en) 2018-02-28 2020-09-29 Novartis Ag 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
WO2020184399A1 (ja) * 2019-03-08 2020-09-17 塩野義製薬株式会社 抗菌用医薬組成物
US20220332728A1 (en) * 2019-09-06 2022-10-20 Nabriva Therapeutics GmbH Siderophore cephalosporin conjugates and uses thereof
CN114846016A (zh) * 2020-01-22 2022-08-02 上海森辉医药有限公司 头孢类抗菌化合物及其在医药上的应用
TW202220663A (zh) 2020-07-28 2022-06-01 日商鹽野義製藥股份有限公司 含有具有鄰苯二酚基之頭孢菌素類的凍結乾燥製劑及其製造方法
US20240132518A1 (en) * 2021-01-12 2024-04-25 Shanghai Senhui Medicine Co., Ltd. Cephalosporin antibacterial compound and preparation method therefor
CN113698365A (zh) * 2021-08-30 2021-11-26 成都大学 一种头孢地尔侧链的制备方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47168A (en) 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS57118588A (en) 1981-11-26 1982-07-23 Toyama Chem Co Ltd Novel cephalosporin
DE3207840A1 (de) 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
AU2361184A (en) 1983-01-21 1984-07-26 Beecham Group Plc Disubstituted 6-penicillins and 7-cephalosporins
NO165842C (no) 1984-04-23 1991-04-17 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
EP0168177A3 (en) 1984-06-28 1987-04-01 Pfizer Limited Cephalosporin antibiotics
NO166283C (no) 1985-03-01 1991-06-26 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(5-amino-1,2,4-tiadiazol-3-yl)-2(z)-substituertoksyiminoacetamido)-3-(heterocyclylmetyl)-3-cefem-4-karboksylsyrederivater.
JPH068300B2 (ja) 1985-08-02 1994-02-02 萬有製薬株式会社 新規セフアロスポリン誘導体
EP0211656A3 (en) 1985-08-10 1988-03-09 Beecham Group Plc Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
JPH07107069B2 (ja) * 1985-09-03 1995-11-15 大塚化学株式会社 セフアロスポリン化合物の新規誘導体、その製造法及び該誘導体を含有する医薬組成物
CA1299564C (en) * 1985-09-03 1992-04-28 Akihiro Shimabayashi Cephalosporin derivative
JPS62158291A (ja) * 1986-01-07 1987-07-14 Sagami Chem Res Center セフアロスポリン誘導体
WO1987006232A1 (en) * 1986-04-14 1987-10-22 Banyu Pharmaceutical Co., Ltd. 1-carboxy-1-vyniloxyiminoaminothiazole cephalosporing derivatives and process for their preparation
ATE110386T1 (de) * 1986-04-14 1994-09-15 Banyu Pharma Co Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und antibakterielle präparate.
IE61679B1 (en) 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
GB8719875D0 (en) 1987-08-22 1987-09-30 Beecham Group Plc Compounds
JPH0228185A (ja) 1988-04-14 1990-01-30 Tanabe Seiyaku Co Ltd セファロスポリン化合物及びその合成中間体
US5149803A (en) * 1988-05-10 1992-09-22 Imperial Chemical Industries Plc Intermediates for cephalosporin compounds
GB8811055D0 (en) 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
PH25965A (en) 1988-06-06 1992-01-13 Fujisawa Pharmaceutical Co New cephem compounds which have antimicrobial activities
US5244890A (en) 1988-06-06 1993-09-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
GB8813945D0 (en) * 1988-06-13 1988-07-20 Fujisawa Pharmaceutical Co New cephem compounds & process for preparation thereof
GB8817653D0 (en) * 1988-07-25 1988-09-01 Fujisawa Pharmaceutical Co New cephem compounds & processes for preparation thereof
CA2005787A1 (en) 1988-12-29 1990-06-29 Masao Wada Cephalosporin compounds
JPH02275886A (ja) 1988-12-29 1990-11-09 Tanabe Seiyaku Co Ltd セファロスポリン化合物及びその製法
US5143910A (en) 1989-09-07 1992-09-01 Shionogi & Co., Ltd. Piperaziniocephalosporins
GB9005246D0 (en) 1990-03-08 1990-05-02 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
US5234920A (en) 1990-08-23 1993-08-10 Bristol-Myers Squibb Company Antibiotic C-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof
US5095012A (en) 1990-08-23 1992-03-10 Bristol-Myers Squibb Company Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
US5194433A (en) * 1990-11-13 1993-03-16 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
GB9111406D0 (en) 1991-05-28 1991-07-17 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
GB9118672D0 (en) 1991-08-30 1991-10-16 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
EP0628562A1 (fr) 1993-06-10 1994-12-14 Roussel Uclaf Céphalosporines comportant en position 7 un radical oxymino substitué, leurs intermédiaires, leurs procédé de préparation et leur application comme médicaments
AU1694099A (en) 1997-12-26 1999-07-19 Cheil Jedang Corporation Cephem derivatives and a method for producing the compounds and an antibacterialcomposition containing the compounds
NZ527276A (en) 2001-03-27 2004-11-26 Actelion Pharmaceuticals Ltd 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists
JP2003078440A (ja) 2001-08-30 2003-03-14 Kyocera Corp 高周波スイッチ回路
TW200305422A (en) 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
US6713625B2 (en) 2002-05-23 2004-03-30 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of cefditoren using the thioester of thiazolylacetic acid
JP4892926B2 (ja) 2005-10-25 2012-03-07 宇部興産株式会社 スルホン化芳香族ブロック共重合体の製造方法
JP3928086B2 (ja) 2005-03-29 2007-06-13 塩野義製薬株式会社 ３−プロペニルセフェム誘導体
JP4557859B2 (ja) 2005-09-29 2010-10-06 富士通株式会社 周波数分割多重送受信装置及び送受信方法
WO2007096740A2 (en) 2006-02-20 2007-08-30 Orchid Research Laboratories Limited Novel cephalosporins
US20090012054A1 (en) 2006-03-16 2009-01-08 Astellas Pharma Inc. Cephem Compounds and Use as Antimicrobial Agents
MY155655A (en) 2008-10-31 2015-11-13 Shionogi & Co Cephalosporin having catechol group
WO2011125966A1 (ja) 2010-04-05 2011-10-13 塩野義製薬株式会社 擬似カテコール基を有するセフェム化合物
EP2557082A4 (en) 2010-04-05 2013-08-28 Shionogi & Co CEPHEM COMPOUND COMPRISING A CATÉCHOL GROUP
US9085589B2 (en) 2010-04-28 2015-07-21 Shionogi & Co., Ltd. Cephem derivative

Also Published As

Publication number Publication date
MY155655A (en) 2015-11-13
CN102203100B (zh) 2014-08-27
EP2960244A1 (en) 2015-12-30
BRPI0921701B8 (pt) 2022-06-07
DK2960244T3 (en) 2016-11-28
JP2014065732A (ja) 2014-04-17
SI2960244T1 (sl) 2017-02-28
ME02666B (me) 2017-06-20
LTPA2020530I1 (lt) 2020-11-10
NL301067I2 (nl) 2020-10-28
SMT201600397B (it) 2017-01-10
KR20110090982A (ko) 2011-08-10
JPWO2010050468A1 (ja) 2012-03-29
MA32731B1 (fr) 2011-10-02
WO2010050468A1 (ja) 2010-05-06
EP2341053A1 (en) 2011-07-06
MX2011004636A (es) 2011-06-20
HUS2000042I1 (hu) 2020-11-30
US9238657B2 (en) 2016-01-19
NL301067I1 (el) 2020-10-13
BRPI0921701B1 (pt) 2022-05-03
KR101655961B1 (ko) 2016-09-08
AU2009310959B2 (en) 2015-05-07
AU2009310959A1 (en) 2010-05-06
FR20C1050I1 (el) 2020-11-27
TWI535727B (zh) 2016-06-01
UA105190C2 (ru) 2014-04-25
US20110190254A1 (en) 2011-08-04
IL211720A (en) 2015-01-29
EP2341053A4 (en) 2012-08-08
EA201170632A1 (ru) 2011-12-30
BRPI0921701A2 (pt) 2020-08-11
PT2960244T (pt) 2016-11-02
PE20120010A1 (es) 2012-02-07
ES2564836T3 (es) 2016-03-29
CA2736953C (en) 2017-07-11
HUE031802T2 (en) 2017-08-28
RS55365B1 (sr) 2017-03-31
ES2602969T3 (es) 2017-02-23
CY2020034I2 (el) 2021-05-05
EA019520B1 (ru) 2014-04-30
CO6331443A2 (es) 2011-10-20
NZ591728A (en) 2012-12-21
NO2020035I1 (no) 2020-10-21
PL2960244T3 (pl) 2017-03-31
EP2960244B1 (en) 2016-09-14
IL211720A0 (en) 2011-06-30
LT2960244T (lt) 2016-11-25
CN102203100A (zh) 2011-09-28
JP5498393B2 (ja) 2014-05-21
EP2341053B1 (en) 2016-01-13
CY1118536T1 (el) 2017-07-12
ZA201102024B (en) 2014-08-27
HRP20161408T1 (hr) 2016-12-02
CA2736953A1 (en) 2010-05-06
FR20C1050I2 (fr) 2021-10-15
CR20110144A (es) 2011-09-09
CL2011000939A1 (es) 2011-09-16
FIC20200039I1 (fi) 2020-10-19
TW201020259A (en) 2010-06-01

Similar Documents

Publication Publication Date Title
CY2020034I2 (el) Κεφαλοσπορινη που διαθετει ομαδα κατεχολης
IT1393131B1 (it) Controvento a ingobbamento limitato
DK2427449T3 (da) Vinylindazolylforbindelser
BR112012006859A2 (pt) compostos
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
BRPI0919250A2 (pt) métodos para a purificação de vírus
DE112009003886A5 (de) Kupplungsaggregat
UY33156A (es) Nuevos compuestos tienopirrol
DK2429882T3 (da) Forbindelsesanordning
DE112009003885A5 (de) Kupplungsaggregat
FI20080181A0 (fi) Laippakäämitys
DE112010004333A5 (de) Kupplungsaggregat
BR112012003154A2 (pt) descanso para uma motocicleta
BR112012004643A2 (pt) compostos antibióticos
DE112009001757A5 (de) Kupplungsaggregat
DE112009003303A5 (de) Kupplungsaggregat
DE112010004396A5 (de) Kupplungsaggregat
IT1397375B1 (it) Cassero a disarmo rapido
FR2947315B1 (fr) Palier a roulement
HK1213896A1 (zh) 具有兒茶酚基團的頭孢菌素
FI8370U1 (fi) Kuristin
TH92563B (th) ชาม
FI20085944A0 (fi) Kaasutinlaite
TH104548B (th) ชาม
TH99877B (th) ชาม